Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share (DH)

Q: What does CUSIP 24477E103 represent in this 13F holders report?

CUSIP 24477E103 is the security identifier for DH - Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held DH - Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share in Q2 2025?

120 institutional investors reported DH - Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 24477E103

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Class A Common Stock, par value $0.001 per share
Shares outstanding: 104,139,175
Total 13F shares: 97,972,684
Share change: -4,127,576
Total reported value: $382,095,091
Put/Call ratio: 0%
Price per share: $3.90
Number of holders: 120
Value change: -$10,879,378
Number of buys: 67
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 24477E103?
CUSIP 24477E103 identifies DH - Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 24477E103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DH - Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADVENT INTERNATIONAL, L.P.	3/4/5 13D/G 13F	Director, 10%+ Owner · Company	55% from 13D/G	62,493,676	$562,443,084	—	22 Nov 2021	3/4/5 13D/G 13F
Christopher Egan	3/4/5	Director	— class O/S missing	62,493,676	$562,443,084	—	22 Nov 2021	3/4/5
Lauren Young	3/4/5	Director	— class O/S missing	62,493,676	$562,443,084	—	22 Nov 2021	3/4/5
SEA VII Management, LLC	3/4/5	Director	— mixed-class rows	29,127,973 mixed-class rows	$493,886,222	—	22 Aug 2023	3/4/5
Winn David Randall	3/4/5	Director	— mixed-class rows	2,472,433 mixed-class rows	$78,797,091	—	08 Aug 2022	3/4/5
Jason Ronald Krantz	13D/G	—	17%	22,159,463	$61,381,713	$0	31 Mar 2025	13D/G
GOLDMAN SACHS GROUP INC	13F	Company	8.4%	8,716,725	$25,191,335	—	31 Mar 2025	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13D/G 13F	Massachusetts Financial Services Company · Company	4.3%	4,962,749	$13,746,815	$0	31 Dec 2024	13D/G 13F
BlackRock, Inc.	13F	Company	3.9%	4,084,694	$11,804,765	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	3.7%	3,828,297	$11,063,779	—	31 Mar 2025	13F
Robert W. Musslewhite	3/4/5	Chief Executive Officer, Director	— class O/S missing	1,201,638	$10,814,742	—	07 Jan 2024	3/4/5
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	2.2%	2,265,198	$6,546,422	—	31 Mar 2025	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.9%	1,967,174	$5,685,418	—	31 Mar 2025	13F
Jonathan Maack	3/4/5	PRESIDENT	— class O/S missing	699,650	$4,918,540	—	03 May 2024	3/4/5
STATE STREET CORP	13F	Company	1.3%	1,379,069	$3,985,509	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	1.3%	1,322,517	$3,822,074	—	31 Mar 2025	13F
Carrie Lazorchak	3/4/5	CHIEF REVENUE OFFICER	— class O/S missing	421,528	$3,629,356	—	14 Feb 2024	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	1,241,616	$3,588,832	—	31 Mar 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	0.84%	871,091	$2,517,453	—	31 Mar 2025	13F
Whetstone Capital Advisors, LLC	13F	Company	0.83%	869,275	$2,512,000	—	31 Mar 2025	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.73%	763,367	$2,206,131	—	31 Mar 2025	13F
William Moschella	3/4/5	Chief Product & Tech Officer	— class O/S missing	451,302	$2,193,328	—	21 Jan 2025	3/4/5
Christopher T. Mitchell	3/4/5	Director	— class O/S missing	226,126	$2,035,134	—	23 Aug 2023	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.6%	621,798	$1,796,996	—	31 Mar 2025	13F
Richard Douglas Booth	3/4/5	CHIEF FINANCIAL OFFICER	0.63%	652,630	$1,794,732	—	01 May 2025	3/4/5
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.57%	590,149	$1,705,531	—	31 Mar 2025	13F
Joseph Gianni Mirisola	3/4/5	Chief Revenue Officer	— class O/S missing	185,198	$1,666,782	—	14 Sep 2023	3/4/5
NORTHERN TRUST CORP	13F	Company	0.44%	461,622	$1,334,088	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	458,936	$1,326,325	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.36%	376,605	$1,088,389	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.3%	307,684	$889,207	—	31 Mar 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.29%	299,740	$866,249	—	31 Mar 2025	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.25%	265,000	$765,850	—	31 Mar 2025	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.25%	260,000	$751,400	—	31 Mar 2025	13F
Pinnacle Wealth Management Advisory Group, LLC	13F	Company	0.25%	260,000	$751,400	—	31 Mar 2025	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.24%	250,152	$722,939	—	31 Mar 2025	13F
CLARK ESTATES INC/NY	13F	Company	0.23%	239,630	$692,531	—	31 Mar 2025	13F
ALGERT GLOBAL LLC	13F	Company	0.23%	237,064	$685,000	—	31 Mar 2025	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.22%	223,941	$647,189	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.22%	223,904	$647,082	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.21%	215,977	$624,174	—	31 Mar 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.19%	197,000	$569,330	—	31 Mar 2025	13F
Samuel Allen Hamood	3/4/5	Director	0.15%	151,788	$560,097	—	05 Jun 2025	3/4/5
Sastry Chilukuri	3/4/5	Director	0.12%	126,794	$467,869	—	05 Jun 2025	3/4/5
Scott G. Stephenson	3/4/5	Director	0.12%	124,124	$458,017	—	05 Jun 2025	3/4/5
Kathleen A. Winters	3/4/5	Director	0.12%	119,792	$442,032	—	05 Jun 2025	3/4/5
Jill Larsen	3/4/5	Director	0.11%	114,751	$423,431	—	05 Jun 2025	3/4/5
Cubist Systematic Strategies, LLC	13F	Company	0.14%	144,284	$416,981	—	31 Mar 2025	13F
Verition Fund Management LLC	13F	Company	0.13%	131,843	$381,026	—	31 Mar 2025	13F
Jeffrey C. Haywood	3/4/5	Director	— class O/S missing	41,934	$377,406	—	23 Aug 2023	3/4/5

Institutional Holders of Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share (DH) as of Q2 2025

As of 30 Jun 2025, Definitive Healthcare Corp. - Class A Common Stock, par value $0.001 per share (DH) was held by 120 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 97,972,684 shares. The largest 10 holders included Advent International, L.P., GOLDMAN SACHS GROUP INC, BlackRock, Inc., VANGUARD GROUP INC, PALISADE CAPITAL MANAGEMENT, LP, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, D. E. Shaw & Co., Inc., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 119 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

135

Q2 2025 holders

120

Holder diff

-15

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.